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The O-glycomap of Lubricin, a Novel Mucin
Responsible for Joint Lubrication, Identified by
Site-specific Glycopeptide Analysis*□S
Liaqat Ali‡, Sarah A. Flowers‡, Chunsheng Jin‡, Eric Paul Bennet§,
Anna-Karin H. Ekwall¶, and Niclas G. Karlsson‡
The lubricative, heavily glycosylated mucin-like synovial
glycoprotein lubricin has previously been observed to
contain glycosylation changes related to rheumatoid and
osteoarthritis. Thus, a site-specific investigation of the
glycosylation of lubricin was undertaken, in order to fur-
ther understand the pathological mechanisms involved in
these diseases. Lubricin contains an serine/threonine/
proline (STP)-rich domain composed of imperfect tandem
repeats (EPAPTTPK), the target for O-glycosylation. In
this study, using a liquid chromatography–tandem mass
spectrometry approach, employing both collision-in-
duced and electron-transfer dissociation fragmentation
methods, we identified 185 O-glycopeptides within the
STP-rich domain of human synovial lubricin. This showed
that adjacent threonine residues within the central STP-
rich region could be simultaneously and/or individually
glycosylated. In addition to core 1 structures responsible
for biolubrication, core 2 O-glycopeptides were also iden-
tified, indicating that lubricin glycosylation may have other
roles. Investigation of the expression of polypeptide N-
acetylgalactosaminyltransferase genes was carried out
using cultured primary fibroblast-like synoviocytes, a cell
type that expresses lubricin in vivo. This analysis showed
high mRNA expression levels of the less understood poly-
peptide N-acetylgalactosaminyltransferase 15 and 5 in
addition to the ubiquitously expressed polypeptide N-
acetylgalactosaminyltransferase 1 and 2 genes. This sug-
gests that there is a unique combination of transferase
genes important for the O-glycosylation of lubricin. The
site-specific glycopeptide analysis covered 82% of the
protein sequence and showed that lubricin glycosylation
displays both micro- and macroheterogeneity. The den-
sity of glycosylation was shown to be high: 168 sites of
O-glycosylation, predominately sialylated, were identified.
These glycosylation sites were focused in the central
STP-rich region, giving the domain a negative charge. The
more positively charged lysine and arginine residues in
the N and C termini suggest that synovial lubricin exists as
an amphoteric molecule. The identification of these
unique properties of lubricin may provide insight into the
important low-friction lubricating functions of lubricin dur-
ing natural joint movement. Molecular & Cellular Pro-
teomics 13: 10.1074/mcp.M114.040865, 3396–3409, 2014.
Human diarthrodial joints are surrounded by synovial fluid
(SF),1 a dense extracellular matrix fluid composed of proteins,
glycoproteins, hyaluronic acid, proteoglycans, and phospho-
lipids (1). During movement, the cartilage surfaces of the
articulating joints slide over each other with an extremely low
coefficient of friction that ranges from 0.0005 to 0.04 (2) and
handle pressures up to 200 atm (3). In a healthy state, the
joint surface and SF constitute a system of reduced friction
that results in lifelong lubrication and wear resistance, primar-
ily due to biolubricating molecules such as hyaluronic acid
and lubricin (4). Human synovial lubricin is encoded by the
proteoglycan 4 (Prg4) gene (5, 6) and is synthesized by fibro-
blast-like synoviocytes (FLSs) and superficial zone chondro-
cytes. Its 1404-amino-acid sequence contains a central
mucin-like domain consisting of 59 imperfectly repeated se-
quences of EPAPTTPK. The O-glycosylation (in particular
core 1 and sialylated core 1) of lubricin is suggested to be
responsible for its lubricating properties (7), as the removal of
these residues results in the loss of boundary lubrication. The
molecule has also been suggested to play a key role in pro-
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tecting the cartilage surface from excessive adsorption of
proteins and cells (8).
Arthritis results in the loss of this joint surface, leading to
severe pain and a restricted range of motion. The two most
common arthritic diseases, osteoarthritis (OA) and rheuma-
toid arthritis (RA), have different mechanisms of degradation.
RA is an autoimmune systemic high inflammatory disease that
increases the friction between articulating cartilage surfaces,
resulting in degradation of the joint (9), whereas OA is a result
of mechanical stress (10). Degeneration of the cartilage can
be detected from proteoglycan fragments in the SF (11, 12).
Because of the limited efficacy of available treatments, par-
ticularly for OA, understanding the biological factors related to
arthritis is essential.
The joints of arthritis patients, both RA and OA, have shown
a down-regulation of expression and changes in glycosylation
of lubricin (13). Studies using OA animal models suggest that
there is a relationship between pathogenesis and the down-
regulation of lubricin (9, 14, 15). This decrease in lubricin
expression exacerbates the disease by accelerating the joint
destruction, suggesting that certain characteristics of lubricin
may be indicators of disease progression in RA and OA. Given
the critical nature of lubricin glycosylation, we initiated a site-
specific glycopeptide characterization of the lubricin mucin-
like domain using liquid chromatography–tandem mass spec-
trometry with both collision-induced and electron-transfer
dissociation fragmentation methods (LC-CID/ETD-MS2) after
tryptic digestion of both intact and partly de-glycosylated
lubricin.
Collision-induced dissociation–tandem mass spectrometry
(CID-MSn) ofO-linked (and N-linked) glycopeptides is capable
of generating sequence information both for the attached
glycan (in MS2) and for the de-glycosylated peptide (in MS3),
but it lacks the site-specific information of the modified amino
acids (16). This is due to extensive glycosidic bond cleavage
of the precursor ion in MS2 producing B/C and Y/Z ions
(Domon and Costello carbohydrate fragmentation nomencla-
ture (17)). In addition, the identification of the modified amino
acids is even more difficult for peptides containing several
Ser/Thr residues because of the lack of a consensus se-
quence for mucin-type O-glycosylation. Electron-capture dis-
sociation and ETD are fragmentation techniques used for the
site-specific characterization of protein post-translational
modifications including phosphorylation (18) and glycosyla-
tion (19). Both techniques induce cleavage of the N-C bonds
of the peptide backbone, producing c- and z-type fragment
ions, while leaving the post-translational modification
unaffected.
In order to understand the biosynthesis of O-linked glyco-
proteins, one needs to link site localization of glycosylation to
the expression of enzymes responsible for GalNAc-type (or
mucin-type) O-glycosylation. This is necessary because the
prediction of the site of GalNAc-type O-glycosylation is diffi-
cult. One reason for this is the large, redundant UDP-GalNAc:
polypeptide -N-acetylgalactosaminyltransferase (ppGalNAc
T) gene family containing 20 gene-encoded isoenzymes, all
possessing unique and/or overlapping substrate specificities
(20, 21). These ppGalNAc Ts transfer GalNAc from the sugar
nucleotide donor UDP-GalNAc to the hydroxyl groups of Ser
and Thr residues in the proteins traversing the Golgi/endo-
plasmic reticulum. Altered protein O-glycosylation, suggested
to be due to changes in the expression of distinct ppGalNAc
Ts, has been reported in various disease states, including
ulcerative colitis and cancer (21, 22). Thus, the connection of
site-specific O-glycosylation with the responsible ppGalNAc
Ts is important for understanding the functions of lubricin, as
site-specific O-glycosylation has been shown to regulate the
functions of proteins (23, 24) and may be involved in the
pathological transformation of the joint in arthritis diseases.
Although the type of glycosylation present on lubricin has
been investigated previously, the site-specific glycopeptide
characterization, including the analysis of the glycan types at
these locations, was investigated for the first time in this
study. In order to understand the nature of glycoproteins, it is
essential to not only define the protein component or the
glycan characteristics, but also understand how these two
essential components interact. The macro- (different site oc-
cupation) and micro-heterogeneity (different glycan structure
at each site) provided a heterogeneous mixture of lubricin
O-linked glycopeptides that might help to explain the extraor-
dinary properties of lubricin and how it can function as a
lubricating agent in a demanding environment.
EXPERIMENTAL PROCEDURES
Human Tissues and Cells—Synovial tissue specimens were ob-
tained from patients with RA and OA during joint replacement surgery
at Sahlgrenska University Hospital (Gothenburg, Sweden). Primary
FLS cultures were established using collagenase/dispase and used in
passage 5.
Isolation of Acidic Glycoproteins from SF—SF samples from RA
and OA patients (n  5) were collected during therapeutic joint
aspiration at the Rheumatology Clinic of Sahlgrenska University Hos-
pital. All patients gave informed consent, and the hospital’s ethics
committee approved the procedure. The arthritis patients fulfilled the
American College of Rheumatology 1987 revised criteria for RA (25).
The samples were clarified by centrifugation at 10,000  g for 10 min
and stored at 80 °C before use. The acidic proteins, including
lubricin, were purified from RA and OA samples separately as previ-
ously described (26, 27). Protein concentration was determined with
a bicinchoninic acid protein assay kit using bovine serum albumin as
the standard.
Enzymatic Digestion of Lubricin—Enriched lubricin fractions (30 g)
from RA and OA patients were reduced (20 mM DTT, 70 °C for 1 h)
and alkylated (50 mM iodoacetamide for 30 min at room temperature
in the dark) separately. The DTT (VWR, Radnor, PA) and iodoacet-
amide (Sigma-Aldrich, St. Louis, MO) were removed using a spin filter
with a 30-kDa cutoff (Merck Millipore, Billerica, MA). The samples
were de-sialylated via incubation with 5 mU of sialidase A (Prozyme
Inc., Hayward, CA) at 37 °C for 16 h. Partially de-glycosylated lubricin
was generated after de-sialylation via incubation with 5 mU of O-
glycanase (Prozyme) specific for removal of core 1 type O-glycan
(Gal1–3GalNAc1-O-Ser/Thr) from glycoproteins and glycopeptides
at 37 °C for 4 h in 50 mM sodium phosphate buffer, pH 6.0.
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In order to investigate the accessibility of the heavily O-glycosy-
lated mucin-like domain of lubricin to proteolytic enzymes, the en-
riched sample (in solution) was digested with trypsin (Promega, Mad-
ison, WI) prior to sialidase A and O-glycanase treatment. In brief, the
reduced and alkylated samples were buffer exchanged with 50 mM
ammonium bicarbonate (Sigma-Aldrich) and incubated with trypsin
(1:30 enzyme to protein) at 37 °C for 16 h. The reaction was quenched
by heating the sample in NuPAGE lithium dodecyl sulfate sample
buffer, pH 8.4 (Life Technologies, Carlsbad, CA), at 95 °C for 10 min
prior to loading onto a 3–8% Tris acetate NuPAGE gel (Life
Technologies).
One-dimensional Isoelectric Focusing and Transfer of Proteins from
IPG to Membrane—The concentration of the sample before and after
de-sialylation was adjusted (0.05 to 0.1 mg/ml) by dilution with 7 M
urea, 2 M thiourea (Sigma-Aldrich), and 2% CHAPS (MCLAB, San
Francisco, CA). The sample was reduced with 5 mM tributylphosphine
solution in 2-propanol (Sigma-Aldrich) for 2 h and alkylated with 15
mM iodoacetamide for 1 h at room temperature. Bromphenol blue
tracking dye solution (5 l of 0.2 mg/ml solution; Sigma-Aldrich) was
added prior to the samples’ addition to the rehydration/equilibration
tray. An IPG strip of pH 3–10 (Bio-Rad, Hercules, CA) was placed with
the gel facing the sample. The strip was covered with paraffin oil (to
prevent evaporation), and the gel was rehydrated for 16 h at room
temperature. The proteins in the rehydrated IPG strip were focused
using a Protean IEF Cell (Bio-Rad). A linear gradient in voltage was set
as follows: 100 V in 5 min, then a gradient up to 10,000 V in 8 h. Once
10,000 V was reached, the focusing was continued for an additional
8 h.
The proteins from the IPG gel were transferred to PVDF membrane
via passive diffusion as previously described (28, 29), with minor
changes. Briefly, the IPG strips (gel facing upward), after being
washed with water and soaked in 50 mM Tris buffer (Sigma-Aldrich)
for 10 min, were placed above two filter papers soaked in the same 50
mM Tris buffer. The PVDF membrane (Immobilon P, Millipore), after
being soaked in methanol for 2 min and 50 mM Tris buffer for 10 min,
was placed above the IPG gel, which was covered with two additional
Tris-wetted filter papers. The sandwich was covered in plastic foil and
compressed by a weight of about 4 kg (to ensure good contact), and
the proteins were blotted for 24 h at room temperature. After transfer,
the membrane was washed with water for subsequent immunode-
tection as described in the section “SDS-PAGE Gel Separation, West-
ern Blotting, and Staining.”
RNA Extraction, Reverse Transcription, and Real-time Quantitative
PCR—RNA from primary human FLSs of RA (n  2) and OA (n  2)
patients was extracted separately using an RNeasy Mini Kit (Qiagen,
Valencia, CA), and the concentration was determined with a Nano-
Drop (Thermo Scientific, Wilmington, DE) at 260 and 280 nm.
Taq-man-based real-time PCR was performed on cDNA derived from
RNA using High Capacity cDNA Reverse Transcription Kits as rec-
ommended by the supplier (Applied Biosystems, CA). Profiling of all
20 GALNTs was performed as described previously using -actin as
an internal normalization standard (21).
SDS-PAGE Gel Separation, Western Blotting, and Staining—The
samples before and after enzymatic treatment (trypsin digestion and
partial de-glycosylation) were separated using 3–8% Tris acetate
NuPAGE gels (Invitrogen). The separated proteins were transferred to
PVDF membrane using a semi-dry blotter (Bio-Rad) and probed with
lubricin-specific antibody (mouse anti-lubricin mAb13, Pfizer Re-
search, Cambridge, MA) and carbohydrate-specific biotinylated lec-
tins including peanut agglutinin (PNA) (Vector Laboratories, Burlin-
game, CA) and wheat germ agglutinin (WGA) (Vector Laboratories) as
previously described (12). For peptide and glycopeptide identification,
the SDS-NuPAGE gels were stained with Coomassie Brilliant Blue
(Thermo Scientific, Waltham, MA) for 30 min and de-stained with 5%
aqueous acetic acid.
Cotton Wool Glycopeptide Enrichment—The major Coomassie
Blue–stained protein bands (3–8% Tris acetate NuPAGE gel) before
and after partial de-glycosylation (sialidase and O-glycanase treat-
ment) were excised and subjected to in-gel trypsin digestion (30) for
subsequent LC-MS2 analysis. The generated glycopeptides were also
enriched offline using cotton wool hydrophilic interaction liquid chro-
matography (HILIC) solid phase extraction microtips packed in house
(31). In brief, a microtip (10 l) packed with cotton wool was washed
five times with LC-MS water and conditioned seven times with 83%
acetonitrile (water and acetonitrile were from Merck Millipore). The
samples, solubilized in 83% acetonitrile, were applied by pipetting up
and down at least 25 times. Peptides were eluted with 83% acetoni-
trile containing 0.1% TFA (Sigma-Aldrich), and glycopeptides were
eluted with water. The eluted fractions were concentrated in a vac-
uum centrifuge for subsequent LC-MS2 analysis.
LC-MS2 Analysis of Lubricin—C18 pre- and analytical columns
packed in-house (3-m particles; Dalco Chromtech, Stockholm,
Sweden) were used, with inner diameters of 75 m and lengths of 4
cm and 20 cm, respectively. Mobile phases consisted of aqueous
0.2% formic acid (Sigma-Aldrich) for solvent A and 0.2% formic acid
in 80% acetonitrile for solvent B. A linear gradient was set as follows:
0% B for 5 min, then a gradient up to 35% B in 70 min and to 80%
B in 5 min. A 20-min wash at 80% B was used to keep the column
sensitive and prevent carryover, and a 25-min equilibration with 100%
A completed the gradient. The column was attached to an Agilent
1100 series HPLC (Agilent Technologies, Santa Clara, CA). An LTQ-
Orbitrap XL (Thermo Scientific) was used in positive ion mode for MS
and MS2 analysis. The spray voltage was set to 2 kV, and the ion
transfer tube was set at 200 °C. The full scans were acquired in a
Fourier transform MS mass analyzer that covered an m/z range of
400–2000. The MS2 analysis was performed under data-dependent
mode to fragment the top five precursors using either CID or ETD. For
CID, a normalized collision energy of35 eV, an isolation width ofm/z
1.0, an activation Q value of 0.250, and a time of 30 ms were used. In
the case of ETD, an isolation width of m/z 2.0 and activation times of
100 and 150 ms were used.
Data Analysis—The raw files containing centroid MS2 spectra were
searched against UniProt (AC# Q92954, released February 19, 2014),
NCBI (released August 13, 2013; 251,429 human entries), and Swiss-
Prot (version 2013 05; 20,257 human entries) human protein data-
bases using the in-house version of the Mascot software (v.2.2.04,
Matrix Science Inc., Boston, MA). The raw file was also converted to
mzXML and mgf formats by Software from Seattle Proteome Center
(ReAdW 4.3.1), and searches were carried out using the online GPM
(32) and Byonic software (Protein Matrics, San Carlos, CA) (33). The
search parameters for GPM software were set as follows: peptide
tolerance, 4 ppm; MS2 tolerance, 0.5 Da; enzyme, trypsin; one missed
cleavage allowed; fixed carbamidomethyl modification of cysteines;
and variable modifications of HexNAc (203.0794 Da) of Ser. For
Mascot and Byonic software, variable modifications of HexNAc
(203.0794), HexHexNAc (365.1323), Hex2HexNAc2 (730.2644), and
NeuAcHexHexNAc (656.2278) of Ser and Thr were also included in
the search parameters used for GPM. For positive protein identifica-
tion, the minimum criteria were three unique peptides with scores
above the significance threshold (p  0.05). In the case of glycopep-
tides, the criteria were MS2 spectra that sequenced 75% of the
peptide including the identification of the modified Ser/Thr residue
(glycan location) for positive identification. However, the majority of
the glycopeptide identifications were based on manual interpretation
because of the lack of sufficient glycopeptide information obtained
using the software. The software-identified glycopeptides were all
manually validated.
Site-specific Glycopeptide Analysis of Synovial Lubricin
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The interpretation (manual and software annotation) of the CID-
MS2 glycopeptide spectra generated glycan sequence information.
The presence of oxonium ions (m/z 204 (HexNAc), 292 (NeuAc), 366
(HexHexNAc), etc.) in the CID-MS2 spectra was used to validate
glycopeptides identified by the software. In order to obtain peptide
information, the human synovial lubricin (UniProt Q92954) was theo-
retically trypsin digested using from the Swiss Institute of Bioinfor-
matics. This allowed the comparison of them/z of the de-glycosylated
peptide in MS2 spectra with the theoretically generated peptide list for
peptide identification. The LC-MS2 analyses for RA and OA SF lubri-
cin were carried out separately, and the final data were combined, as
there was no major difference observed in the glycopeptide analyses
of RA and OA SF lubricin.
pI Modeling of Lubricin—The isoelectric point (pI) dependence for
sialic acid of full length and STP-rich regions of lubricin was simulated
as described by Henriksson et al. (34, 35). For pI simulation, the amino
acid composition, pKa values for the amino acid side chains and for
the N- (pKa  8) and C-terminal (pKa  3.1) groups, and presence of
charged sialic acid groups were taken into account. The pKa values
used were Lys 10, Arg 12, His 6, Glu and Asp 4.1, Tyr 10.4, and sialic
acid 2.6 (36).
RESULTS
Accessibility and Characterization of the Glycosylated Re-
gion of Lubricin—Human synovial lubricin was purified from
SF of RA and OA patient samples (n  5). After purification,
lubricin was detected as a major band in both RA and OA
samples through the use of lubricin-specific antibody with an
apparent molecular mass of 200 kDa after SDS-PAGE (Fig.
1A, lane 1). The antibody also detected an additional, faint
high-mass band that was due to lubricin complexes (37). All
bands were previously confirmed to contain lubricin when
subjected to in-gel trypsin digestion and subsequent LC-MS2
analysis (38).
In order to indicate the localization of the glycosylated
mucin-like domain within lubricin, the samples (reduced and
alkylated) were subjected to in-solution trypsin digestion and
separated on SDS-PAGE gels prior to subsequent Western
blotting using lubricin-specific antibody and biotinylated lec-
tins (PNA, Gal1–3GalNAc1-O-Ser/Thr and WGA, sialic
acid, and terminal GlcNAc). The effectiveness of the trypsin
digestion was shown by the fact that the generated peptides
were too small to be detected on the gel (Fig. 1). This showed
that both the less glycosylated N- and C-terminals and the
mucin-like domain were accessible for digestion (Fig. 1A, PNA
and WGA). The lubricin mucin domain is different from tradi-
tional indigestible mucin domains, allowing Lys residues (tryp-
sin cleavage site) in the imperfect repeat EPAPTTPK to be
protease accessible. This also suggested that the glycans of
lubricin were smaller and/or less frequent than other mucins,
allowing the trypsin site to be accessible despite the sur-
rounding glycosylation. The positive lectin (PNA and WGA)
binding of the reduced and alkylated but not trypsin digested
samples suggested that SF lubricin predominantly contained
short core 1 and sialylated core 1 structures (Fig. 1A). This
was further verified by partial de-glycosylation using sialidase
and O-glycanase to remove sialylated and unsialylated core 1
structures. This treatment resulted in a substantial decrease in
size (Fig. 1B), with an apparent mass of 155 kDa, close to
the predicted size of apolubricin (151 kDa).
The dominating lubricin band seen in SDS-PAGE was sub-
jected to in-gel trypsin digestion, and unmodified lubricin
peptides were identified via LC-MS2. The identified peptides
were predominately from the N- and C-terminal regions. Even
though the mucin-like domain was indicated to be less exten-
sively glycosylated, only a few non-modified peptides from
the mucin domain could be identified (Fig. 1C, black). In a
stretch of 507 amino acids in the central region (aa 348–855)
there were only two (one unique) peptides (KPAPTTPK) (3%
coverage) identified. After partial de-glycosylation, a total of
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FIG. 1. Accessibility and characterization of the glycosylated
region of lubricin. A, the enriched synovial lubricin samples, before
and after trypsin digestion, were separated on a 3–8% Tris acetate
gel, blotted onto PVDF membrane, and then probed with lubricin-
specific antibody (mouse anti-lubricin) and carbohydrate-specific
biotinylated lectins PNA, specific for core 1 (Gal1–3GalNAc) O-gly-
can, and WGA, specific for sialic acid and terminal GlcNAc. B, SDS-
PAGE (3–8% Tris acetate gel) of the acidic glycoprotein fractions of
the SF before () and after () partial de-glycosylation stained with
Coomassie Brilliant Blue. C, SF lubricin was in-solution digested, and
non-modified peptides were identified via mass spectrometry for
protein coverage determination (black). The low protein coverage (in
particular the mucin domain) suggests that the mucin domain is
extensively glycosylated. Some of the core 1 structures were re-
moved by partial de-glycosylation, and the previously glycosylated
peptides were identified for protein coverage (gray). The results sug-
gest that lubricin contains an extended STP-rich region relative to the
mucin domain previously defined by UniProt.
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99 (13 unique) unmodified peptides from this lubricin mucin-
like domain were identified via LC-MS2 (Fig. 1C, gray), pro-
viding a coverage of 84% of the mucin-like domain (aa 348–
855) rich in Thr (29.5%), Pro (30.5%), and, to a lesser extent,
Ser (2.4%). These data suggested that this entire region was
highly glycosylated with small glycans, as even though tryptic
peptides could be created, unmodified peptides could not be
identified. The current domain model of lubricin consists of
less glycosylated N and C terminals separated by a glycosy-
lated mucin-like domain (aa 348–855) region of a tandemly
repeated amino acid sequence. However, the data shown
here indicate that lubricin consists of an extended glycosy-
lated STP-rich region (aa 232–1056) (Fig. 4A) larger than the
mucin-like domain previously defined by UniProt. The molec-
ular mass of glycosylated lubricin is estimated to be 350
kDa, and that of apomucin to be 151 kDa, indicating glyco-
sylation constitutes 57% of the total protein mass. Given that
the estimated average mass of an oligosaccharide on lubricin
is 600 to 1000 Da (38), it is expected that lubricin holds 200 to
300 oligosaccharide chains.
Identification of Lubricin Mucin Glycopeptides Using CID
and ETD—In order to analyze the STP-rich region and identify
the number of glycosylation sites on synovial lubricin, we
adopted a combined approach using both CID- and ETD-MS2
to identify the types of glycans attached, as well as their
position. Tryptic glycopeptides of both RA and OA samples
were generated both before and after partial de-glycosylation
(Fig. 1B) for subsequent mass spectrometric analysis. The
LC-CID/ETD-MS2 approach successfully identified 185 O-
glycosylated peptides. They are presented, together with the
identified O-linked glycans, glycan attachment sites, and
annotation method (software or manual) of each individual
glycopeptide, in Table I (and in supplemental Table S1). Pre-
dominantly core 1 and monosialylated core 1 (NeuAc2–
3Gal1–3GalNAc1-) O-linked glycopeptides were identified.
A small proportion of disialylated core 1 (NeuAc2–3Gal1–3
(NeuAc2–6)GalNAc1-) peptides were also detected. The
peptides (KPAPTTPK) identified as non-glycosylated in the
previously defined mucin-like domain and in the STP-rich
region (VLAKPTPK and KPAPTTPK) were also shown to be
glycosylated. The glycosylation of the threonine in the
KPAPTTPK repeat was also shown, as indicated by the data
presented in this report (supplemental Table S1). In addition
to core 1, a small proportion of core 2 (Gal1–3(Gal1–
4GlcNAc1–6)GalNAc1-) and monosialylated core 2 (e.g.
NeuAc2–3(Gal1–3(Gal1–4GlcNAc1–6)GalNAc1-)) gly-
copeptides were also identified. These findings are consistent
with the O-linked glycans identified in our and others’ previ-
ous studies (7, 26, 38).
The CID-MS2 approach effectively identified the nature of
the glycans attached to lubricin. CID-MS2 spectra of four
different O-linked isoforms of the same amino acid sequence
(EPAPTTPK) located in the STP-rich region are presented in
Figs. 2A–2D. The spectrum of the [M2H]2 ions atm/z 603.3
(Gal1–3GalNAc1-O-[EPAPTTPK]) resulted in fragmentation
of the glycan component into y-type ions (Domon and
Costello nomenclature) and b-type ions corresponding to
[HexNAcH] and [HexHexNAcH] oxonium ions at m/z
204 and 366, respectively (Fig. 2A). This corresponded to a
glycopeptide with a core 1 glycan at one of the Thr residues.
The spectrum showed the neutral loss of Hex residue (m/z
1043.6), which was followed by a loss of HexNAc residue (m/z
840.3), establishing the glycan sequence as Hex-HexNAc.
However, the CID-MS2 spectrum did not show which of the
Thr residues was glycosylated. The sialylated version of this
glycopeptide was also identified (Fig. 2B). The presence of an
oxonium ion at m/z 292 (sialic acid, NeuAc) in the CID-MS2
spectrum of the [M2H]2 ions at m/z 748.8 (NeuAc-Hex-
HexNAc-O-[EPAPTTPK]) showed that this glycopeptide can
also be sialylated (Fig. 2B). The loss of a NeuAc residue (m/z
1205.3) followed by the loss of Hex (m/z 1043.3) and finally the
loss of HexNAc (m/z 840.5) indicated a NeuAc-Hex-HexNAc-
structure attached to a Thr residue in the peptide sequence
(Fig. 2B). This, together with previous O-glycan analysis, sug-
gested that the attached structure was
NeuAc2–3Gal1–3GalNAc1-O-Thr.
The CID-MS2 spectra allowed the identification of isomeric
glycopeptides, showing differences in the number of glyco-
sylation sites and glycan sequences. The presence of diag-
nostic ions atm/z 407 [HexNAc2H]
 and 569 [Hex(HexNAc)-
HexNAcH] (Fig. 2D) were used to differentiate a single
substituted core 2 O-glycan from a doubly substituted core 1
O-glycan on both Thr residues in EPAPTTPK repeats. These
results indicated that there were heavily glycosylated regions
of the STP-rich region, such as the doubly glycosylated
EPAPTTPK repeat shown in Fig. 2C. The STP region also
displayed more complex O-glycosylation such as the core 2
structure shown in Fig. 2D.
ETD-MS2 analysis was used for the identification of glyco-
sylation sites within the STP-rich region, particularly for the
identification of non-consensus repeats. Generally, the ETD-
MS2 highly charged glycopeptide precursor ions fragmented
efficiently, allowing the site of glycosylation to be further nar-
rowed down, in most cases to single amino acid residues
(Table I and supplemental Table S1). All ETD-MS2 spectra
were manually annotated for verification of the location of
uniquely modified Ser/Thr residues in order to remove all
possible ambiguity.
The ETD-MS2 spectrum of the [M3H]3 ions at m/z 673.3
glycopeptide (K972ITTLKTTTLAPK985V) allowed the identifica-
tion of the glycan-modified Thr residues within the peptide
sequence. The ETD-MS2 spectrum, [M3H]3 ions at m/z
673.3 (Fig. 3A), displayed the z101-, z91-, and c7-ions at
m/z 1788.6, 1687.8, and 1506.6, respectively, indicating that
Thr974, Thr975, and Thr980 were unmodified. However, the
c6-ion at m/z 1040.4 was observed with the addition of a
Hex-HexNAc residue (365 Da), indicating that the Thr979 was
modified with an unsialylated core 1 structure. The c5-ion at
Site-specific Glycopeptide Analysis of Synovial Lubricin
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m/z 574.4 showed that the adjacent Thr978 was modified with
a second Hex-HexNAc residue (Fig. 3A). The z7-ion at m/z
1444.7 denoted that the two core 1 glycans (Hex-HexNAc)
were still intact and attached to the peptide. However, the
z51-ion at m/z 513.2 confirmed that both Thr
978 and Thr979
were core 1 modified, as it was the loss of two threonines and
two Hex-HexNAc- units. Lubricin displayed macroheteroge-
neity as shown by the identification of an isomeric glycopep-
tide (Fig. 3B). The ETD-MS2 spectrum of the [M3H]3 ions
at m/z 673.3 indicated the same peptide sequence
(K972ITTLKTTTLAPK985V) with two core 1 glycans on separate
threonine residues (Fig. 3B). The c7-ion at m/z 1141.6 indi-
cated the loss of the Hex-HexNAc Thr980. The c6-ion at m/z
1040.6 was the loss of unmodified Thr979. The Thr978 was
modified with the second Hex-HexNAc residue identified by
the c5-ion at m/z 574.5, the loss of Thr
978 with a HexHexNAc.
The c5-ion at m/z 574.5, a peptide with two core 1 glycans,
indicated that Thr974 and Thr975 were unmodified. The
TABLE I
A list of the CID- and ETD-identified glycopeptides with their peptide sequence, types of glycans, position in the peptide sequence, and
annotation method used
Lubricin peptide Glycancompositiona Assignment
b Annotation Lubricin peptide Glycancomposition Assignment Annotation
c
K.STTK.R 2, 3 CID Manual K.KAPPSGASQTIK.S 3, 4 Both Both
K.STTKR.S 3 CID Manual K.APPPSGASQTIK.S 3, 4 Both Manual
R.SPKPPNKK.K 3 CID Manual K.VTTPDTSTTQHNK.V 3 Both Manual
K.VSTSPK.I 1, 3 CID Both K.ITTAKPINPR.P 3 ETD Both
K.ETTVETK.E 3 CID Manual K.ETSLTVNKETTVETK.E 4 ETD Both
K.ETTTTNK.Q 3, 4 CID Both K.ETTVETKETTTTNK.Q 3 ETD Both
K.TTSAK.E 3, 6 CID Manual K.ETTTTNKQTSTDGK.E 3 CID Manual
K.DLAPTSK.V 1, 2, 3, 5, 8, 10, 11 CID Manual K.TTSAKETQSIEK.T 1, 3, 4 Both Both
K.VLAKPTPK.A 1, 3, 4 Both Both K.ETQSIEKTSAK.D 3, 4 Both Both
K.GPALTTPK.E 1, 3, 4 CID Manual K.TSAKDLAPTSK.V 1, 3, 4, 5, 10 Both Both
K.EPTPTTPK.E 1, 3 CID Manual K.EPTPTTPKEPASTTPK.E 3 CID Manual
K.EPASTTPK.E 1, 3 CID Manual K.EPTPTTIKSAPTTPK.E 3, 4 CID Manual
K.EPTPTTIK.S 1, 3, 8 CID Manual K.SAPTTPKEPAPTTTK.S 1, 3 ETD Both
K.EPAPTAPK.K 3, 8, 10 CID Manual K.EPAPTTTKEPAPTTPK.E 3 Both Both
K.EPSPTTPK.E 1, 3 CID Manual K.EPAPTTTKEPAPTTTK.S 3 Both Manual
K.SAPTTTK.E 1 CID Manual K.SAPTTPKEPAPTTPK.K 1, 3 ETD Both
K.EPSPTTTK.E 6, 8 ETD Both K.EPAPTTPKEPTPTTPK.E 3 CID Manual
K.ETAPTTPKK.L 3 Both Both K.EPTPTTPKEPAPTTK.E 8 CID Manual
K.KLTPTTPEK.L 1, 3 Both Manual K.EPAPTTPKEPAPTAPK.K 3 Both Both
K.LTPTTPEK.L 3 Both Both K.EPAPTTTKEPSPTTPK.E 3 CID Manual
K.AAAPNTPK.E 3, 4, 8, 10 CID Manual K.SAPTTTKEPAPTTTK.S 1, 3 ETD Both
K.GTAPTTLK.E 3, 4, 8, 10 CID Manual K.SAPTTPKEPSPTTTK.E 1, 6 ETD Both
K.ELAPTTTK.E 1, 3 Both Manual a.EPAPTTPKETAPTTPK.a 3 ETD Both
K.GTAPTTPK.E 1, 3 CID Manual K.GTAPTTLKEPAPTTPK.K 3 ETD Both
K.GPTST TSDK.P 1, 3 ETD Both K.EPAPTTPKKPAPK.E 3 ETD Manual
K.EPTTIHK.S 8, 10 CID Manual K.GPTSTTSDKPAPTTPK.E 1 ETD Both
K.ALENSPK.E 3, 4 CID Manual K.ETAPTTPKEPAPTTPK.K 3 ETD Both
K.EPGVPTTK.T 1, 3, 4, 10 Both Manual K.SPDESTPELSAEPTPK.A 3, 4 CID Manual
K.ETATTTEK.T 1, 3 CID Manual K.ALENSPKEPGVPTTK.T 1, 3 Both Manual
K.TTTLAPK.V 1, 2, 3 CID Manual R.TTPETTTAAPK.M 3 Both Manual
K.VTTTK.K 3 CID Manual K.ITTLKTTTLAPK.V 1, 3 ETD Manual
R.ATNSK.A 3 CID Both K.ITATTTQVTSTTTQDTTPFK.I 1, 3 ETD Both
K.KPTSTK.K 1, 3, 4 CID Manual K.KPTSTKKPK.T 1, 3, 4, 5, 8, 10 CID Manual
K.TMPR.V 3 CID Manual R.KPKTTPTPR.K 1, 3, 8 CID Both
K.TTPTPR.K 1, 3, 4 CID Manual R.NGTLVAFR.G 1, 6, 10 CID Manual
aa.EPAPTTPK.aa 1, 3, 4, 8, 10 CID Manual K.ETAPTTPK.K 1, 3 Both Manual
aa.EPAPTTTK.aa 1, 3, 8 CID Manual K.EPAPTTTKSAPTTPK.E 3 CID Manual
K.KPAPTTPK.E 1, 3 CID Both K.SAPTTPK.E 1, 3, 8 CID Manual
Notes: The line under an amino acid in a peptide sequence represents the position of glycosylation. The data showed glycosylation of
threonine in the EPAPTTPK and KPAPTTPK repeats and two of the three sites in SAPTTPK and EPAPTTTK.
a 1, GalNAc1-; 2, NeuAc2–6GalNAc1-; 3, Gal1–3GalNAc1-; 4, NeuAc2–3Gal1–3GalNAc1-/NeuAc2–6(Gal1–3)GalNAc1-; 5,
NeuAc2–3Gal1–3(NeuA2–6)GalNAc1-; 6, GlcNAc-GalNAc1-; 7, NeuAc2–6(GlcNAc1–3)GalNAc1-; 8, Gal1–3(GlcNAc1–6)
GalNAc1-; 9, NeuAc2–3Gal1–3(GlcNAc1–6)GalNAc1-; 10, Gal1–3(Gal1–4GlcNAc1–6)GalNAc1-; 11, NeuAc2–3Gal1–3 (Gal1–
4GlcNAc1–6)GalNAc1-. Sequence assumed based on identified sequences on lubricin (38).
bAssignment based on MS/MS using CID, ETD, or both types of fragmentation.
cGlycopeptide MS/MS spectra identified by means of manual annotation or both manual and software-assisted annotation.
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ETD-MS2 spectra of the isomeric [M3H]3 ion at m/z 673.3
(Figs. 3A and 3B) revealed the site occupancy within the
glycopeptide K972ITTLKTTTLAPK985V of SF lubricin.
Overall, the dual fragmentation approach identified 185 lu-
bricin glycopeptides, primarily from the STP-rich region. This
allowed us to characterize 168 glycosylation sites, predomi-
nantly in the STP-rich region (aa 232–1056), covering 71% of
the Ser/Thr in this STP-rich region. This, together with the
identified non-glycosylated Ser/Thr (mainly in the N and C
termini), covered 72% of the Ser/Thr (266 out of 370 Ser/Thr
were identified) in the entire protein sequence. The Ser/Thr
coverage provided one of the most extensive O-glycosylation
maps of a mucin-type protein (supplemental Fig. S2 and
supplemental Table S1). The identified glycosylated and non-
glycosylated Ser/Thr (both in the N and C termini and in the
STP-rich region) are shown in supplemental Fig. S2. In addi-
tion to the Ser/Thr coverage, the mass spectrometric ap-
proach covered 82% of the entire protein sequence, and the
coverages for the N terminus (aa 1–231), STP-rich region (aa
232–1056), and C terminus (aa 1057–1404) were 79%, 80%,
and 85%, respectively.
The O-glycosylation Map of Lubricin—The identified O-gly-
copeptides, glycan composition, fragmentation technique,
annotation technique (software/manual), and glycosylation
sites are listed in Table I (and in supplemental Table S1).
Regions of glycosylation sites identified via CID and ETD both
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FIG. 2. Identification of lubricin mucin glycopeptides using CID.
The figure shows the different glycoforms of the same tryptic peptide
within the STP-rich region. A, CID-MS2 spectrum of the tandem
repeat (EPAPTTPK) containing core 1 glycan (Gal1–3GalNAc1-) of
the [M2H]2 ions at m/z 603.3. B, CID-MS2 spectrum of the
same tandem repeat containing sialyl T antigen (NeuAc2–3Gal1–
3GalNAc1-) of the [M2H]2 ions at m/z 748.8. C, CID-MS2 spec-
trum of the same tandem repeat (EPAPTTPK) containing two separate
core 1 glycans (Gal1–3GalNAc1-) on two adjacent threonines of the
[M2H]2 ions at m/z 785.8. D, CID-MS2 spectrum of the same
tandem repeat containing core 2 glycan Gal1–3(Gal1–4GlcNAc1–
6)GalNAc1- of the [M2H]2 ions at m/z 785.8. This shows that the
same peptide (A, B, and D) can be differently glycosylated, indicating
the complexity associated with lubricin O-glycosylation, and that CID
was able to provide information about the nature of glycans and
peptides. In the figure, yellow squares and circles represent N-acetyl-
galactosamine and galactose, respectively, and blue squares and
pink diamonds represent N-acetylglucosamine and N-acetyl-
neuramininc acid (sialic acid), respectively.
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FIG. 3. Identification of glycosylation sites using electron trans-
fer dissociation (ETD). A, ETD-MS2 spectrum of the [M3H]3 ions
at m/z 673.3 indicates a tryptic peptide (ITTLKTTTLAPK) with two
separate core 1 glycans (Gal1–3GalNAc1-) on two adjacent thre-
onine residues. B, ETD-MS2 spectrum of the [M3H]3 ions at m/z
673.3 reveals the same tryptic peptide (ITTLKTTTLAPK) with two
separate core 1 glycans (Gal1–3GalNAc1-) on two separate thre-
onine residues, indicating that lubricin glycosylation displays macro-
heterogeneity within the same peptide sequence. M denotes the
glycopeptide parent mass.
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before and after partial de-glycosylation are shown in Fig. 4A.
The identified O-glycopeptides characterized 168 glycosyla-
tion sites. This indicated that 63% of the identified Ser/Thr
residues (266 Ser/Thr, both glycosylated and non-glycosy-
lated, were identified) in lubricin were O-glycan modified (Fig.
4B) with a bias toward Thr glycosylation due to the high Thr
content (supplemental Fig. S2). An extended STP-rich region
was also apparent spanning amino acids 232–1056, larger
than the previously defined mucin-like domain suggested in
UniProt. The entire lubricin molecule has in total 370 potential
O-glycosylation sites. Of these, 35% of Ser/Thr (130 glycans)
were HexNAc (GalNAc) modified with a distribution through-
out the extensively glycosylated STP-rich region (Fig. 4B).
Core 1 modified (43%, 161 glycans) and larger core 2 modi-
fied (23%, 85 glycans) glycopeptides were also identified (Fig.
4B). The high-abundant core 1 modified Ser/Thr were uni-
formly distributed throughout the STP-rich region, whereas
the low-abundant core 2 modified residues were limited to the
previously defined mucin-like domain (aa 348–856) (Fig. 4B).
This was likely because the accumulative nature of glycopep-
tides from the repeat region made them easier to detect, and
it might not necessarily be a reflection of core 2 enrichment in
the repeat area. Outside the STP region, only a single GalNAc-
modified Thr (1159NGTLVAFR1166) was identified. This resi-
due, in the hemopexin 1 domain (1148–1191), was also
shown to be glycosylated with core 2 structures (Figs. 4A and
4B; supplemental Fig. S1; supplemental Table S2).
The identification of core 2 glycopeptides confirmed the
presence of core 2 structures on lubricin. The identification of
core 2 together with single HexNAc (GalNAc)-modified glyco-
peptides suggested that lubricin glycosylation might also
have other roles in addition to lubrication. The majority of the
GalNAc extended into either core 1 or core 2 sialylated struc-
tures (73 glycans; Fig. 4B). Both mono- and disialylated core
1 and core 2 modified Ser/Thr were identified (Table I and
supplemental Table S1), but monosialylation was more prev-
alent, which is consistent with previously identified synovial
lubricin O-glycans (38).
Comparison of the Lubricin O-glycomap with Predicted O-
glycosylation Sites—The glycosylations identified here were
compared with currently available O-glycosylation prediction
tools. The glycosylation prediction tool NetOGlyc4.0 (39) is
based on in vivo identifiedO-glycosylation sites and predicted
almost double the number of O-glycosylation sites identified
here (almost 90% of all Ser/Thr residues) (Fig. 4C). In addition
to the STP-rich region, most of the Ser/Thr residues in the
N-terminal region were predicted to be O-glycosylated (Fig.
4C). An individual ppGalNAc T in vitro enzymatic specificity–
based prediction tool, ISOGlyP (40), predicted that 51% (191)
of the sites were glycosylated (Figs. 4C and 4D) utilizing all
ppGalNAc T specificities available in the tool. This prediction
is closer to the 168 detected in this study (Fig. 4B). ISOGlyP
predicted that a high proportion of the Thr in the STP-rich
region would be glycosylated, as was also shown by the MS
analysis (Table I, supplemental Fig. S2, supplemental Table
S1). However, no single ppGalNAc T of those included in the
tool was able to glycosylate all the sites identified via MS. The
ubiquitously expressed GALNT1 and -2 were suggested to
glycosylate only 76% of the total sites found via MS (Fig. 4D).
In total, 166 out of 191 (87%) sites predicted by the nine
available genes in the software were identified through MS
analysis (Fig. 4D). This suggested that a GALNT not included
in ISOGlyP might be responsible for at least some of the
glycosylation on synovial lubricin (Fig. 4D and supplemental
Table S2).
Investigating the Expression of Glycosyltransferase Genes
and Glycosylation—An alternate method for understanding
glycosylation is to investigate the Golgi apparatus glycosyl-
transferases responsible for glycosylating lubricin. Because
the ISOGlyP results suggested less common transferases
were necessary for lubricin glycosylation, the expression of
ppGalNAc Ts from human primary FLSs isolated from RA and
OA patients was investigated. These types of cell lines are
known to produce lubricin (1). The relative quantifications of
all transcripts were normalized against -actin expression.
The average (n  4, except for GALNT8, where n  3) ex-
pression of the GALNT genes is arranged in descending order
of expression in Fig. 4D. High mRNA expression was ob-
served for GALNT1, -2, -5, and 15, and lower expression was
noted for the GALNT8, -10, -12, and 16 genes. The high
expression of GALNT1 and -2 was in agreement with the
suggestion that these two genes are ubiquitously expressed.
In contrast, GALNT5 and GALNT15 have been shown to
display restricted expression profiles, suggesting these iso-
forms serve unique functions in the tissue where they are
expressed (21). The high expression of GALNT5 in FLSs indi-
cated a potential role of this gene, and its relevance is increas-
ing, as the expression of this gene has also been shown in
chondrocytes (neXtProt). The GALNT5 gene was also able to
correctly predict 54% of the sites identified via MS (Fig. 4D),
which also indicates potential involvement of this gene in
lubricin glycosylation. The data showed that the highest ex-
pression was of the GALNT15 gene in the FLS cultures. The
specificity of this enzyme toward mucin-type domains is not
currently understood (41), making its further investigation es-
sential, especially as the gene has been shown to be one of
the most expressed genes in chondrocytes and bone (21, 42).
The Implications of the Identification of the Site-specific
Glycosylation of Lubricin and Its Role in Lubrication—Sialy-
lated and sulfated glycans will alter the charge of heavily
glycosylated proteins. Apomucins are usually neutral or
acidic, secreted with a predicted pI of 2 to 4.7 (43, 44). The
predicted pI of apolubricin is exceptional in this respect in that
it can be as high as 9.8, but the protein can end up acidic after
glycosylation. With a detailed glycosylation map, the depen-
dence of glycosylation and the amount of sialylation for the
charge and pI of the lubricin can be modeled (Fig. 4B). Given
that the majority of glycans of lubricin are mono- rather than
Site-specific Glycopeptide Analysis of Synovial Lubricin
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disialylated (Table I and supplemental Table S1), an upper
limit of 168 possible sialic acid residues was suggested. The
positive charge buffering capacity of lubricin required 60
sialic acids to give the STP-rich region of lubricin a negative
charge at the physiological pH (7.2–7.4) of SF (43). An addi-
tional 10 sialic acids were required to render the whole lubricin
negatively charged (Fig. 5A). Beyond 80 sialic acids, lubricin
and its STP-rich region both were negatively charged and
capable of maintaining the negative charge during pH shifts of
SF and/or limited chemical/enzymatical agents that partially
lowered the sialic acid content of lubricin. This is likely the
number of sialic acid residues required in order for lubricin to
sustain its function on the cartilage surface. We carried out
isoelectric focusing before and after de-sialylation in order to
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identified peptides and the fact that two threonines in the imperfect tandem repeat variants (e.g. EPAPTTPK, SAPTTPK, EPAPTTTK) can be
glycosylated. It indicates a high number of glycosylations in the STP-rich region, whereas the N- and C-terminal regions are scarcely
glycosylated. C, the combined CID and ETD identified glycopeptides in the STP-rich region (black and dark gray) and non-glycosylated
peptides (light gray) in the end domains of lubricin before (black) and after partial de-glycosylation (dark gray). The software used (NetOGlyc4.0
and ISOGlyP) predicted sites of lubricin O-glycosylated Ser/Thr in the protein sequence (yellow) and the total number of potential Ser/Thr sites
(370). The results indicate that the gene-based ISOGlyP software predicted a similar number of glycosylation sites (191 sites) as identified by
the data presented in this report (168 sites). D, the GALNT profiling expression analysis of the 20 known human GALNT genes (top) in primary
FLSs and the ISOGlyP-predicted sites by the available GALNT genes identified by the data presented in this report (bottom). The genes were
arranged in descending order of their expression. RQ, relative quantification. Asterisk denotes genes not included in the ISOGlyP software.
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better understand the contribution of sialic acid to the phys-
ical properties of lubricin. The pI of lubricin before de-sialyla-
tion ranged from 4 to 7.5 in a chaotropic environment (Fig.
5B), whereas after de-sialylation the pI of lubricin was 7.5.
This suggests that the removal of sialic acids changed the
molecule from highly acidic to basic and that in addition to the
N and C termini, the mucin domain also became positively
charged because of the presence of abundant Lys residues
and the loss of sialic acid.
This analysis showed that lubricin is an amphoteric, mucin-
like molecule with a negatively charged central domain that
can become highly hydrated due to its glycosylation and is
flanked by positively charged unglycosylated regions (pI
9.49–9.98) (Fig. 5C). The substantial change in the pI and the
drastic alteration of the charge of lubricin with around 60 to 70
sialic acids indicates that there is a critical point where the
number of glycosylation sites (controlled by the ppGalNAc Ts)
and the amount of sialic acid (controlled by sialyltransferases)
will significantly alter the properties of lubricin. This shows
that pathological alteration of the glycosylation of lubricin may
contribute to an altered lubricating surface of articular joints.
Overall, in this study we used a combined CID/ETD-MS2
fragmentation approach to successfully characterize the
heavily glycosylated STP-rich region of lubricin and identify an
unprecedented 168 glycosylation sites on a single protein.
This approach allowed the identification of not only the site of
glycosylation, but also its nature, providing a new understand-
ing of the nature of this unique zwitterionic protein. The use of
prediction software uncovered the potential importance of
novel transferases, which was confirmed by GALNT expres-
sion showing that the less understood GALNT5 and -15 were
highly expressed in FLSs.
DISCUSSION
Decreased expression and increased degradation of lubri-
cin have been suggested in the joints of RA and OA patients,
making the changing characteristics of lubricin a potential
indicator of arthritic disease progression. In addition to
boundary lubrication, suggested to be established by core 1
O-glycosylation, the multiple protein domains of lubricin may
serve other biological functions, such as the protection of
chondrocytes and signaling (45). The method adopted in this
study allowed us to investigate the specific location of glycans
on lubricin. The combination of CID and ETD methods not
only enabled evaluation of the protein component and the
location of the glycosylation, but also provided details of the
attached glycan. Although this was a very effective approach,
manual interpretation of CID/ETD-MS2 data was essential
because of the lack of universal software in the field of gly-
coproteomics. The detailed analysis allowed further under-
standing of the zwitterionic nature of the protein. The inclusion
of molecular biology to evaluate the expression of important
FIG. 5. The implication of the type
and distribution of O-glycosylation on
the charge and role of lubricin as a
lubricating agent. A, the predicted iso-
electric point (pI) of full-length (black)
and STP-rich regions (dark gray) for
varying numbers of sialic acids identi-
fied, indicating that the pI decreases as
the number of sialic acids increases. B,
enriched acidic SF fractions, before and
after sialidase treatment, were separated
on pH 3–10 IPG gels and blotted to
PVDF membrane. Western blot analysis
using lubricin-specific antibody (mAb13)
indicated a pH range of synovial lubricin
before sialidase treatment (pH 4–7.5)
and a drastic increase in pH (pH 7.5)
after sialidase treatment. C, the pI of the
N- (9.45–9.6) and C-terminal regions
(9.69–9.98) (light gray), where very few
glycosylation sites were identified, and
the extended STP-rich region, which
contained the majority of the protein gly-
cosylation (4–7.5).
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glycosyltransferases of this highly specialized tissue showed
that it has a very different profile from other tissues of the
body.
Western blot analysis revealed that unlike that of traditional
mucous-forming mucin (46), the mucin-like domain of lubricin
could be completely digested by trypsin (Figs. 1A and 1C).
Extensive degradation of lubricin by papain and Pronase and
partial degradation by pepsin have also been reported previ-
ously (47). In addition to these, neutrophil elastase (a serine
protease) and cathepsin B (a cysteine protease) have also
been shown to degrade lubricin in vitro (13, 48). Given that
lubricin was found to have an abundance of closely located
occupied glycosylation sites, this suggests that it was the
smaller size, rather than a smaller number of glycans, that
made lubricin more enzyme accessible than other heavily
glycosylated proteins such as mucins.
The glycans identified included the previously reported re-
leased O-linked glycans of lubricin (7, 26, 38). However, the
confirmation of core 2 O-linked glycans, identified as core 2
glycopeptides from the previously defined mucin-like domain
(aa 348–855), and the site-specific glycopeptide character-
ization of lubricin (in particular the STP-rich region) are shown
for the first time in this report. Core 2 structures are the
oligosaccharide precursors of inflammatory epitopes such as
sialyl Lewis x and sulfated sialylated type 2 structures (49).
These types of structures on lubricin have previously been
indicated to influence joint inflammation (38). Core 2 struc-
tures can also have other functions—for example, cell surface
glycans reduce cell–cell interaction (50) and can even be used
as cell surface markers to distinguish effector and memory
CD8 T cells (51).
CID-MS2 fragmentation of the O-linked glycopeptides pro-
duced sequence information for different glycoforms of the
same tryptic peptide (EPAPTTPK) (Figs. 2A–2D). This showed
that lubricin glycosylation displayed both macro- (two sepa-
rate core 1–like glycans) and site-specific micro-heterogene-
ity (different glycans at a single amino acid position) (Figs. 2C
and 2D). However, because CID-MS2 resulted in extensive
glycosidic fragment ions, it was not always possible to identify
the site-specific location of the glycan in peptides with more
than one Thr or Ser (Figs. 2A, 2B, and 2D). To overcome this,
ETD was used as an additional technique for the site-specific
identification of glycans because it induces peptide backbone
cleavage, leaving the glycan unaffected. An additional com-
plication of ETD fragmentation in this study was the abun-
dance of the small repeat (EPAPTTPK), as its low mass re-
duces the higher charge state advantages of ETD. Therefore,
it was the novel combined use of CID and ETD that allowed
the site-specific glycan localization and glycan determination
of this difficult protein. The site-specific glycopeptide analysis
(Fig. 4B) redefined the mucin-like domain to an extended
STP-rich region (aa 232–1056). This was due to the identifi-
cation of extensive O-linked glycopeptides (e.g. peptide
K972ITTLKTTTLAPK985V found outside the repeat domain
showing four out of five glycosylated sites) in the vicinity of the
tandem repeat region of the previously defined mucin repeat
domain suggested by UniProt (Figs. 4A and 4B).
In contrast to N-linked glycosylation, the identification of
O-glycan attachment sites is made more difficult by the lack
of a consensus sequence and the heterogeneity associated
with extensive O-glycosylation. The recent increase in O-gly-
can data has allowed the development of prediction tools
including NetOGlyc4.0 and ISOGlyP. It was obvious for lubri-
cin glycosylation that without knowledge about the types of
transferases present, the specificity of software such as
NetOGlyc4.0 (39), based on neural network predictions of
mucin type O-glycosylation sites from all 20 GalNAc Ts, will
have some limitations (Fig. 4C). In contrast, software such as
ISOGlyP (40), based on individual glycosyltransferase predic-
tion specificity, is likely to be more successful (Figs. 4C and
4D). ISOGlyP predicted 191 O-glycosylation sites, more sim-
ilar to the data presented in this report (168 Ser/Thr O-linked
glycosylation sites). Interestingly, the MS data identified a
GalNAc and core 2 modified Thr (1159NGTLVAFR1166) in the
hemopexin 1 domain of the C-terminal region (Figs. 4A and
4B; Table I; supplemental Fig. S1), which was not predicted to
be glycosylated by either of the software programs (supple-
mental Table S2). This might indicate a potential regulatory
role associated with a particular ppGalNAc T, as the C-termi-
nal recombinant construct of lubricin has been shown to be
involved in binding to the cartilage surface (43).
The GALNT profiling expression analysis using primary
FLSs showed high expression of the ubiquitous GALNT1 and
-2 genes. In addition, high expression levels of GALNT5 and,
particularly, GALNT15 were also shown. GALNT5 has been
shown to exhibit a restricted expression pattern (21), including
expression in chondrocytes (neXtProt). GALNT15 has been
suggested to have a broader expression pattern; its dominant
expression in the FLSs indicated a particular role in the syno-
vial tissue. The identification of GALNT15 as the 17th most
abundant enzyme in chondrocytes (42) indicated that this less
studied enzyme could be particularly important for the glyco-
sylation of synovial lubricin.
The site-specific glycopeptide analysis showed that major-
ity of lubricin O-glycans were composed of core 1 structures
with terminal galactose (Table I and supplemental Table S1).
Terminal galactose is a ligand for galectins, known to increase
expression during RA (52) and suggested, along with fibrino-
gen, to play a pro-inflammatory role by regulating neutrophil
activation and degranulation (53). The high proportion of sia-
lylated core 1 glycopeptides identified has biosynthetic im-
portance, as the sialic-acid-terminated glycan end cannot be
extended any further by glycosyltransferases in the Golgi/
endoplasmic reticulum (54). This might also explain the low
proportion of core 2 structures identified as core 2 glycopep-
tides, which could be a consequence of low core 2 GlcNAc
transferase activity or high sialyltransferase activity, or both.
The high proportion of sialylated core 1 glycans on lubricin
Site-specific Glycopeptide Analysis of Synovial Lubricin
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reduces the possibility of the formation of larger, potentially
immunologically reactive glycans, restricting lubricin to short,
negatively charged glycans.
The terminal domains of lubricin have a large number of
positively charged arginine and lysine residues, whereas the
STP-rich region is negatively charged because of the at-
tached sialic acid, making lubricin an amphoteric polyelectro-
lyte. Lubricin is suggested to be a good lubricant for nega-
tively charged surfaces such as the surface of the outermost
layers (lamina splendens) of the articular cartilage. This is
mainly due to an increase in repellent charge forces between
the negatively charged STP-rich region and the negatively
charged components of the outermost layers of the cartilage
such as hyaluronic acid, lipids, and proteoglycans (55). The pI
of synovial lubricin ranged from 4 to 7.5 as measured by
isoelectric focusing (Figs. 5B and 5C). De-sialylation in-
creased the pI substantially to close to 7.5 (Fig. 5B). The lower
pI relative to the theoretical calculation for apolubricin (pI 9.8)
is likely due to the influence of the pKa of individual amino
acid residues by the chaotropic reagants and the remaining
sulfated residues on the lubricin oligosaccharides (38). Al-
though lubrication might not be totally dependent on sialic
acid, it might be enhanced through an increase in repellent
charge forces due to an increase in negative charges around
the STP-rich region domain (55).
The terminal somatomedin B-like and hemopexin-like do-
mains have been shown to promote integrin-mediated attach-
ment of cells to the extracellular matrix (6, 8). It has also been
reported that lubricin lacking these end domains binds only
weakly to the cartilage surface (56). This weak binding is
suggested to result in inefficient lubrication (43). Therefore, it
can be speculated that for efficient lubricin function, both
positively charged end domains and the negatively charged
STP-rich region are essential.
Concluding Remarks—The mass spectrometric site-spe-
cific glycopeptide characterization performed in this study
mapped the glycosylation profile of lubricin within the STP-
rich region and indicates that lubricin glycosylation displays
both micro- and macroheterogeneity. The presence of two
adjacent simultaneously glycosylated Thr residues in the con-
sensus repeat unit EPAPTTPK indicated that there are regions
within the lubricin domain that are highly glycosylated. The
data presented here redefine an extended STP-rich region
relative to the mucin domain previously defined by UniProt.
Screening of ppGalNAc Ts from primary FLSs showed high
expression of the less understood GALNT15 and GALNT5
genes, indicating that lubricin glycosylation is unique. Overall,
this study showed that heavy glycosylation, particularly sialy-
lation, is essential for creating the amphoteric nature of lubri-
cin, a property that may facilitate its efficient biolubrication
function.
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